Vicapsys Life Sciences, Inc. (VICP)
PNK · Biotechnology
Sources: Yahoo Finance (quote, statistics) · SEC EDGAR (filings, insider trades, 13F holders) · company filings & press wires
Company overview
Vicapsys Life Sciences, Inc. focuses on the development and commercialization of VICAPSYN, a proprietary product. The company's product is applied to transplantation therapies and related stem-cell applications in the transplantation field. It also develops VYBRIN, a product based on CXCL12 for prevention of post-surgical adhesions in abdominal surgery, coating of implantable medical devices and other implants to eliminate fibrosis, and wound healing with a focus on diabetic ulcers. The company was formerly known as Phage Therapeutics International, Inc. and changed its name to Vicapsys Life Sciences, Inc. in September 2017. Vicapsys Life Sciences, Inc. was incorporated in 1997 and is based in Suwanee, Georgia.
Peers in Healthcare
Vicapsys Life Sciences, Inc. has no peer companies in this window.
Recent press releases
Vicapsys Life Sciences, Inc. has not issued a press release in this window.
SEC filings
All filings →Vicapsys Life Sciences, Inc. has not filed an SEC document in this window.
Insider trades
All insider trades →Vicapsys Life Sciences, Inc. has no reported insider trades in the last 90 days.
Institutional holders
All holders →No 13F holdings have been reported for Vicapsys Life Sciences, Inc. in this window.